Alissa Marrapodi

As a veteran, RN, and PTSD survivor, Cherissa Jackson has made it her mission to educate veterans about PTSD and cannabis as a treatment option and to create inclusivity for women veterans.

C.J. Carter, Kentucky State Director of Minorities for Medical Marijuana, shares the details about his lifelong relationship with cannabis, how it helps his epilepsy, being a cannabis advocate in the Bluegrass state, and his work around cannabis education and legalization.

Kevin Boehnke, PhD, a research investigator at the Chronic Pain Institute Research Center in the anesthesiology department at the University of Michigan, discusses his research efforts to address questions such as what health conditions are patients using cannabis for, which dosage formats are they using, and does it help chronic pain.

CBD is a growing industry. In this article, topicals and their growing popularity are discussed.

Ann M. Brum and Wayne Smith discuss their roles as cannabis advocates fighting for reform and veteran access to medical cannabis.

Dr. Linda Klumpers discusses her interest in neuroscience, her most significant work, success stories from Cannify—an online science-matching tool—and more.

Wes Burk, cofounder and vice president of Emerald Scientific, discusses this year's Emerald Conference, some of Emerald’s other initiatives in cannabis science, and their plans going into 2020

John S. Abrams, PhD, discusses some of the cutting-edge work he’s involved in and what he’s looking forward to at this year's Emerald Conference.

NMU and SSI collaborated to establish the Shimadzu Analytical Core Laboratory for Medicinal Plant Sciences for NMU’s undergraduate degree program in medicinal plant chemistry.

On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.

November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.

Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.

Aryn Sieber, the founder and CEO of CBD Essentials and Cannaisseur Brands as well as the founder of CannaCauses Foundation, discusses his experiences as a 9/11 first responder, his battle with stage IV cancer, and how cannabis impacted his life.

Dr. Andrea Holmes discusses how she’s using colorimetric analysis to discover novel minor cannabinoids, the potential role of smartphone compatibility in detection, what’s next for cannabinoid research, and more.